Nevolat: The UK Saxenda Replacement (Patient Information)
Patient information about Nevolat (liraglutide), the generic equivalent of Saxenda in the UK. Not an advertisement and not medical advice.
How this guide was checked
TreatCompare uses published provider fees, official regulator registers, NHS/PBS/Medicare references where relevant, and the methodology described on our methodology page. If a clinic, provider or reader spots information that is out of date, they can use our corrections page. Prices are point-in-time and can change before booking.
Most useful next step
Compare current Weight Loss options
This guide explains the costs. The live comparison pages show the current prices, providers and next actions.
Continue from this guide
Turn this Weight Loss article into a comparison
Article visitors often need one of three routes next: provider prices, a calculator, or a related guide that narrows the decision.
Important information for UK consumers. Nevolat (liraglutide) is a prescription-only medicine (POM) in the UK. UK regulations restrict the advertising of prescription medicines to the public, so this article is general patient information — it is not an advertisement, not an offer of sale, and not medical advice.
Background
Saxenda (liraglutide 6mg/ml) was discontinued. Nevolat is the generic equivalent that replaced it, with the same active ingredient at the same dose. Both are administered as a daily subcutaneous injection following a stepped dose-escalation schedule under prescriber guidance.
| Aspect | Nevolat | Saxenda (discontinued) |
|---|---|---|
| Active ingredient | Liraglutide 6mg/ml | Liraglutide 6mg/ml |
| Manufacturer | Zentiva | Novo Nordisk |
| Administration | Daily subcutaneous injection | Daily subcutaneous injection |
| Dose schedule | 0.6mg → 1.2mg → 1.8mg → 2.4mg → 3mg | Identical to Nevolat |
| UK status | Available with private or NHS prescription | Discontinued |
What to discuss with a UK prescriber
- Whether Nevolat is clinically appropriate for your circumstances, given other GLP-1 options.
- The dose escalation schedule and tolerability monitoring approach.
- Whether weekly GLP-1 medicines (where licensed) may be more convenient than a daily injection.
For the full Nevolat patient-information page see Nevolat — UK Patient Information.
If you have spotted an error
Please tell us via the corrections route.
Frequently asked questions
What is Nevolat?
Nevolat (liraglutide) is a daily injectable prescription-only medicine manufactured by Zentiva. It contains the same active ingredient as the discontinued brand Saxenda, at the same dose, and is the generic equivalent that replaced it in the UK.
Why does this article not show Nevolat prices?
Nevolat is a prescription-only medicine in the UK. UK Human Medicines Regulations 2012 prohibit advertising prescription medicines to the public. TreatCompare does not display UK Nevolat prices.
Get an email when prices change
Free alerts when a new provider lists, or the lower-cost published price falls. Confirm by email; unsubscribe in one click.
We'll send a confirmation link first. No marketing — alerts only. Unsubscribe with one click in any email.
Compare prices from verified providers
Weight Loss Injection Prices
Compare Mounjaro, Wegovy, Ozempic, and Nevolat prices from verified GPhC-registered UK pharmacies. Checked weekly.
Related articles
GLP-1 Weight-Management Medicines in the UK: Patient Information (2026)
Patient information about the GLP-1 receptor agonists used for weight management or type 2 diabetes in the UK — Mounjaro, Wegovy, Ozempic, Rybelsus, Nevolat. No prescription-medicine prices.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.
Mounjaro in the UK: Patient Information
General patient information about Mounjaro (tirzepatide) in the UK and the service-level cost components of a UK private weight-management consultation. Not an advertisement and not medical advice.
Mounjaro Maintenance Dose in the UK: Patient Information
General patient information about the Mounjaro (tirzepatide) maintenance-dose phase in the UK. Not an advertisement and not medical advice.